{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:08:53Z","timestamp":1774930133253,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaad.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:48:53Z","timestamp":1602269333000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery"],"prefix":"10.1016","volume":"84","author":[{"given":"Spyros M.","family":"Siscos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett C.","family":"Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali Hocker","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.H.","family":"Hocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.10.008_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1524-4725.2012.02490.x","article-title":"The management of antithrombotic medication in skin surgery","volume":"38","author":"Callahan","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib2","first-page":"1170","article-title":"2016 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaad.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaad.2014.11.013","article-title":"Novel oral anticoagulants: what dermatologists need to know","volume":"72","author":"Plovanich","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.21037\/atm.2017.06.65","article-title":"Direct oral anticoagulants: analysis of worldwide use and popularity using Google trends","volume":"5","author":"Lippi","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib8","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib13","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00266-002-2055-1","article-title":"Complications of minor cutaneous surgery in patients under anticoagulant treatment","volume":"26","author":"Kargi","year":"2002","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaad.2004.07.058","article-title":"A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery","volume":"51","author":"Syed","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib16","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.jvca.2019.08.046","article-title":"Anesthesiologists guide to the 2019 AHA\/ACC\/HRS focused update for the management of patients with atrial fibrillation","volume":"34","author":"Dalia","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"11","key":"10.1016\/j.jaad.2020.10.008_bib17","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2020.10.008_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcjo.2013.11.007","article-title":"New oral anticoagulants and oculoplastic surgery","volume":"49","author":"Ing","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaad.2020.10.008_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaad.2020.10.008_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ajg.2013.228","article-title":"New anticoagulants and antiplatelet agents: a primer for the clinical gastroenterologist","volume":"109","author":"Parekh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2020.10.008_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaad.2020.10.008_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2012.04630.x","article-title":"Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy","volume":"10","author":"Spyropoulos","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaad.2020.10.008_bib23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2020.10.008_bib24","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaad.2020.10.008_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euy148","article-title":"Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events","volume":"21","author":"Nakamura","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jaad.2020.10.008_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jth.13670","article-title":"Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease","volume":"15","author":"Shaw","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaad.2020.10.008_bib27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaad.2017.05.038","article-title":"Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: a retrospective study","volume":"77","author":"Antia","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/DSS.0000000000001394","article-title":"A retrospective assessment of postoperative bleeding complications in anticoagulated patients following Mohs micrographic surgery","volume":"44","author":"Eilers","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4065\/78.11.1392","article-title":"Continuation of medically necessary aspirin and warfarin during cutaneous surgery","volume":"78","author":"Otley","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2020.10.008_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaad.2005.09.047","article-title":"Perioperative evaluation and management in dermatologic surgery","volume":"54","author":"Otley","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib31","first-page":"992","article-title":"Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy","volume":"28","author":"Alam","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib32","first-page":"756","article-title":"Cutaneous surgery in patients receiving warfarin therapy","volume":"27","author":"Alcalay","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1524-4725.1997.tb00065.x","article-title":"Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study","volume":"23","author":"Billingsley","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaad.2011.02.012","article-title":"Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications","volume":"65","author":"Bordeaux","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1067\/mjd.2003.47","article-title":"Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation","volume":"48","author":"Kovich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1524-4725.2000.00079.x","article-title":"Postoperative stroke after stopping warfarin for cutaneous surgery","volume":"26","author":"Schanbacher","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2020.10.008_bib37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaad.2014.10.027","article-title":"A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons","volume":"72","author":"Brown","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.10.008_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220328152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220328152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:26Z","timestamp":1759273166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220328152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0190962220328152"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.10.008","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}